http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18919018

Outgoing Links

Predicate Object
contentType Journal Article
issn 2072-6694
issueIdentifier 1
pageRange 34-
publicationName Cancers
startingPage 34
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7eac63c6caca3f277a919cf515cbd062
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2564d8a6c76a0b9056f3916e9628ca1b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebef78427b5e9ffc5ad452f5057a03
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_57a0fb736775e57072621b0bf917dfcb
bibliographicCitation Chen YA, Tzeng DTW, Huang YP, Lin CJ, Lo UG, Wu CL, Lin H, Hsieh JT, Tang CH, Lai CH. Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers (Basel). 2018 Dec 31;11(1). PMID: 30602706; PMCID: PMC6356781.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d18814218e833d2a28028e89b0f55e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7145-784X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_767ff81a38326f7cd74e601890483189
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dfff789d2a14d921bed4baab6d13331
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da374f74c7a5108d5b0b46661d883c26
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7113-8352
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_959daffcc7db197c574c19d8518af5f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2495eda7f4d549cc42315f544cf1e4af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3edbc2594392cba063765bf1c01dd560
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8b7a38a7616e567f191032bb0733447
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36edb826b7a879d15d85911144dc21f2
date 2018-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC6356781
https://pubmed.ncbi.nlm.nih.gov/30602706
https://doi.org/10.3390/cancers11010034
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37563
https://portal.issn.org/resource/ISSN/2072-6694
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b8d304c86dfe0b8e23510a970edced37
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53474706
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 39.